Versartis Inc (VSAR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
30 Pages - GLDATA58123
$250.00

Summary

Versartis Inc (Versartis) is a biopharmaceutical company that develops therapeutic proteins for the treatment of endocrine disorders. The company provides product such as VRS-317, a human growth hormone which consists of recombinant human growth hormone and the natural hydrophilic amino acids. Its VRS-317 is designed to reduce the burden of daily injection therapy which is used in the treatment of growth hormone deficiency in both children and adults. Versartis utilizes half-life extension technology (XTEN), a proprietary recombinant polypeptide. The company completed Phase 2a clinical trial of VRS-317 in children evaluating weekly, semi-monthly and monthly dosing regimens. Versartis is headquartered in Menlo Park, California, the US.

Versartis Inc (VSAR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Versartis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Versartis Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Versartis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Versartis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Versartis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Versartis Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Versartis Raises US$55 Million In Series E Financing 10
Versartis Raises US$20 Million In Series D Financing 12
Versartis Raises US$25 Million In Series C Financing 14
Versartis Secures US$21 Million In Series B Financing Round 16
Licensing Agreements 18
Teijin Pharma Enters into Licensing Agreement with Versartis 18
Diartis Pharma Enters Into Licensing Agreement With Versartis For VRS-859 20
Equity Offering 21
Versartis Prices Public Offering of Shares for USD60 Million 21
Versartis Prices Public Offering of Shares for USD75 Million 23
Versartis Completes IPO Of For US$145 Million 25
Versartis Inc - Key Competitors 27
Key Employees 28
Locations And Subsidiaries 29
Head Office 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Versartis Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Versartis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Versartis Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Versartis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Versartis Inc, Deals By Therapy Area, 2010 to YTD 2016 8
Versartis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Versartis Raises US$55 Million In Series E Financing 10
Versartis Raises US$20 Million In Series D Financing 12
Versartis Raises US$25 Million In Series C Financing 14
Versartis Secures US$21 Million In Series B Financing Round 16
Teijin Pharma Enters into Licensing Agreement with Versartis 18
Diartis Pharma Enters Into Licensing Agreement With Versartis For VRS-859 20
Versartis Prices Public Offering of Shares for USD60 Million 21
Versartis Prices Public Offering of Shares for USD75 Million 23
Versartis Completes IPO Of For US$145 Million 25
Versartis Inc, Key Competitors 27
Versartis Inc, Key Employees 28

List of Figures
Versartis Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Versartis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Versartis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Versartis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Versartis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Versartis Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Versartis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Versartis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838